Exposant 2025

Exposant 2025

BIOLEGEND

https://www.biolegend.com/fr-fr


38 rue Berri
75008 PARIS
FRANCE


Jean-Baptiste GUILLERME
FAS / Team Lead France & Benelux
jean-baptiste.guillerme@revvity.com


Tél : +33 6 85 72 00 91

BioLegend from Revvity develops world-class, cutting-edge antibodies and reagents for biomedical research including our Cell-Vive™ GMP portfolio of ancillary products specifically designed and manufactured for ex vivo cell processing and downstream manufacturing. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value and with superior customer and technical support. Our product expertise covers a diverse set of research areas including Immunology, Neuroscience, Cancer, Stem cells, and Cell Biology. BioLegend's reagents are manufactured in our state-of-the-art facility in San Diego, CA and are supported by superior customer service and a quality management system that is certified for ISO 13485:2016.

Actualités

BIOLEGEND ELIMINATES FEEDER CELLS FROM NK CELL MANUFACTURING WITH NEW CELL-VIVE ACTIVATION BEADS

September 17, 2025

Natural killer (NK) cells are emerging as a transformative force in cancer immunotherapy, offering unique advantages including innate tumor recognition, potent cytotoxicity, and the potential for off-the-shelf therapeutic applications. However,...

Learn more

BIOLEGEND CELL-VIVE PORTFOLIO ADVANCES REGENERATIVE MEDICINE WITH COMPLETE MSC

September 17, 2025

Mesenchymal stem cells (MSCs) represent a cornerstone of modern regenerative medicine, offering remarkable differentiation and immunomodulatory properties. BioLegend's Cell-Vive™ MSC Xeno-Free Growth Media, GMP, addresses critical manufacturing needs with a...

Learn more
Voir toutes les actualités

Retrouvez-aussi